跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
醫學科技學院
臺北醫學大學
電話
+886-2-27361661#7601
電子郵件
[email protected]
網站
http://comst.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(106)
專案
(1440)
研究成果
(8216)
資料集
(386)
指紋
查看啟用 醫學科技學院 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
61%
Mouse
46%
Disease
43%
Liver Cell Carcinoma
28%
Lung Cancer
26%
Prostate Cancer
25%
Breast Cancer
25%
Cohort Study
25%
Colorectal Cancer
25%
Inflammation
21%
Epidermal Growth Factor Receptor
20%
Glioblastoma
20%
Reactive Oxygen Metabolite
17%
Biological Marker
17%
Tumor Growth
17%
Cancer Growth
17%
IC50
17%
Non Small Cell Lung Cancer
17%
Phosphotransferase
17%
Mitogen Activated Protein Kinase
16%
Lipopolysaccharide
15%
Cytotoxicity
15%
Chronic Kidney Failure
15%
Carcinogenesis
14%
Chemotherapy
14%
Cytokine
13%
Protein P53
13%
Western Blot
13%
Antioxidant
13%
Nuclear Factor
13%
Cyclooxygenase 2
13%
Brain Ischemia
13%
Metastasis
13%
Tumor Necrosis Factor
12%
Anticarcinogen
12%
Parkinson's Disease
12%
Lung Adenocarcinoma
12%
microRNA
12%
Integrin
12%
Drug Resistance
11%
Caspase 3
11%
Injury
10%
Histone Deacetylase Inhibitor
10%
Alternative Complement Pathway C3 C5 Convertase
10%
Combination Therapy
10%
Nitric Oxide
10%
Colon Cancer
10%
Antiplatelet
10%
Diabetes Mellitus
10%
Nanoparticle
9%
Mouse Model
9%
Thrombin
9%
Traumatic Brain Injury
9%
Cisplatin
9%
Infection
9%
Receptor
8%
Alzheimer's Disease
8%
Adverse Event
8%
Tubulin
8%
Mitogen Activated Protein Kinase 3
8%
Prevalence
8%
Anti-Inflammatory Drug
8%
Small Interfering RNA
8%
Protein Kinase C
8%
Cell Viability
8%
Temozolomide
8%
Chronic Obstructive Lung Disease
8%
Cardiovascular Disease
8%
Mouth Cancer
7%
Histone Deacetylase
7%
Hemodialysis
7%
Asthma
7%
Inducible Nitric Oxide Synthase
7%
Comorbidity
7%
Neuroprotective Agent
7%
Transforming Growth Factor
7%
Survival Rate
7%
Case-Control Study
7%
Ovary Cancer
6%
Overall Survival
6%
Randomized Controlled Trial
6%
Adenosine Triphosphate
6%
Pancreas Cancer
6%
Gelatinase B
6%
Resveratrol
6%
Androgen
6%
Sorafenib
6%
Antitumor Activity
6%
Thyroid Hormone
6%
Clinical Trial
6%
Catenin
6%
Mitogen Activated Protein Kinase P38
6%
Recurrent Disease
6%
Epidermal Growth Factor
6%
Mouth Squamous Cell Carcinoma
6%
Caspase
6%
Leukemia
6%
Histone Deacetylase 6
5%
Androgen Receptor
5%
Medicine and Dentistry
Malignant Neoplasm
39%
Neoplasm
35%
Cancer Cell
32%
Metastatic Carcinoma
25%
Apoplexy
24%
Disease
23%
Breast Cancer
23%
In Vitro
22%
Cohort Analysis
21%
Prostate Cancer
18%
Programmed Cell Death
18%
Odds Ratio
16%
Hepatocellular Carcinoma
16%
Lung Cancer
16%
Meta-Analysis
16%
Biological Marker
15%
Colorectal Cancer
15%
Hazard Ratio
14%
Diabetes
12%
Signal Transduction
12%
Logistic Regression Analysis
12%
Carcinogenesis
12%
Gene Expression
12%
Chronic Kidney Disease
11%
Glioblastoma
11%
Cancer Growth
11%
Brain Ischemia
10%
Epidermal Growth Factor Receptor
10%
Cancer
10%
Systematic Review
10%
Case-Control Study
10%
Injury
9%
Cell Proliferation
9%
Radiation Therapy
9%
Tumor Progression
9%
Upregulation
9%
Non Small Cell Lung Cancer
9%
Medicine
8%
Parkinson's Disease
8%
Prevalence
8%
Traumatic Brain Injury
8%
COVID-19
8%
Oral Cancer
8%
Proportional Hazards Model
8%
microRNA
8%
Drug Therapy
8%
Randomized Controlled Trial
8%
Symptom
7%
Infection
7%
Diabetes Mellitus
7%
Platelet
7%
Reactive Oxygen Species
7%
Health Care Cost
7%
Tumor Cell
6%
Magnetic Resonance Imaging
6%
Overall Survival
6%
Mitogen-Activated Protein Kinase
6%
Cell Death
6%
Cancer Therapy
6%
Cytotoxicity
6%
Autophagy
6%
Protein Expression
6%
Alzheimer's Disease
6%
down Regulation
6%
Survival Rate
6%
Lung Adenocarcinoma
6%
Maturity Onset Diabetes of the Young
6%
Protein P53
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Ovarian Cancer
6%
Drug Resistance
6%
Mouth Squamous Cell Carcinoma
6%
Tumor Microenvironment
5%
Xenograft
5%
Integrin
5%
Cell Migration
5%
Phosphotransferase
5%
Nasopharynx Carcinoma
5%
Mesenchymal Stem Cell
5%
Retrospective Cohort Study
5%
Endothelial Cell
5%
Mesenchymal-Epithelial Transition
5%
Chronic Obstructive Pulmonary Disease
5%
Carcinoma Cell
5%
Recurrent Disease
5%
Ganglioglioma
5%
Ischemic Heart Disease
5%
Health Care
5%
Cancer Stem Cell
5%
Macrophage
5%
Oxidative Stress
5%
Diagnosis
5%
Combination Therapy
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
72%
Mouse
28%
Gene Expression
27%
Signal Transduction
20%
Carcinogenesis
19%
MicroRNA
18%
Promoter Region
16%
Cell Proliferation
16%
Kinase
16%
Phosphotransferase
16%
Messenger RNA
16%
Epidermal Growth Factor Receptor
15%
Cohort Study
14%
Autophagy
14%
Upregulation
13%
Stem Cell
13%
down Regulation
13%
Drug Resistance
12%
Tumor Progression
12%
Eicosanoid Receptor
12%
Anticancer
12%
Integrin
12%
Protein Expression
11%
Cell Migration
11%
Mesenchymal-Epithelial Transition
11%
Single-Nucleotide Polymorphism
11%
P53
11%
Fibroblast
11%
Catenin
11%
Colon
10%
Macrophage
10%
Genotyping
9%
Cell Death
9%
Transcription
9%
Overall Survival
8%
Genetics
8%
Cancer Stem Cell
8%
Thyroid Hormone
8%
Platelet
8%
Cell Growth
8%
Enzyme
8%
Cytotoxicity
8%
Cyclooxygenase
8%
Cell Cycle
8%
Synapsin I
7%
Western Blot
7%
Genetic Divergence
7%
Mitogen-Activated Protein Kinase
7%
Angiogenesis
7%
Methylation
7%
Oxidative Stress
7%
Survival Rate
7%
Allele
7%
RNA
7%
Cytokine
7%
Histone Deacetylase
6%
STAT3
6%
Prevalence
6%
Mitochondrion
6%
Antineoplastic Activity
6%
Case-Control Study
6%
Wild Type
6%
Proteomics
6%
T Cell
6%
N-Terminus
6%
Thrombocyte Activation
6%
Transcription Factors
6%
Microarrays
5%
Computer Model
5%
IC50
5%
Lipopolysaccharide
5%
Estrogen Receptor
5%
Interleukin 8
5%
Extracellular Signal-Regulated Kinases
5%
Epigenetics
5%
Small Interfering RNA
5%
Small Molecule
5%
Cisplatin
5%
P38 Mitogen-Activated Protein Kinases
5%
Cell Invasion
5%
Metabolic Pathway
5%
Genome-Wide Association Study
5%
Hemodialysis
5%
Gene Signature
5%
Androgen Receptor
5%
MMP9
5%
Gelatinase B
5%
Gene Expression Profiling
5%